Lindsay A Renfro

Lindsay A Renfro

UNVERIFIED PROFILE

Are you Lindsay A Renfro?   Register this Author

Register author
Lindsay A Renfro

Lindsay A Renfro

Publications by authors named "Lindsay A Renfro"

Are you Lindsay A Renfro?   Register this Author

35Publications

945Reads

42Profile Views

Definitions and statistical properties of master protocols for personalized medicine in oncology.

J Biopharm Stat 2018 9;28(2):217-228. Epub 2017 Oct 9.

a Division of Biomedical Statistics and Informatics , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10543406.2017.1372778DOI Listing
July 2019

Point estimation following two-stage adaptive threshold enrichment clinical trials.

Stat Med 2018 09 31;37(22):3179-3196. Epub 2018 May 31.

Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/sim.7831
Publisher Site
http://dx.doi.org/10.1002/sim.7831DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175016PMC
September 2018

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.

N Engl J Med 2018 Mar;378(13):1177-1188

From the Divisions of Medical Oncology (A.G.) and Biomedical Statistics and Informatics (Q.S., J.P.M., L.A.R., D.J.S.), Mayo Clinic, Rochester, MN; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Martino-IST, Genoa (A.F. Sobrero), Ospedale Papa Giovanni XXIII, Bergamo (R.L.), and IRCCS Mario Negri Institute for Pharmacological Research, Milan (V.T.) - all in Italy; Karmanos Cancer Institute, Wayne State University, Detroit (A.F. Shields); National Cancer Center Hospital East, Chiba (T. Yoshino), Yokohama City University School of Medicine, Yokohama (T. Yamanaka), and the University of Tokyo, Tokyo (T.W.) - all in Japan; the Institute of Cancer Sciences, University of Glasgow, Glasgow (J.P.), the University of Oxford, Oxford (R.K.), Christie Hospital, Manchester (M.S.), and University Hospital Southampton, Southampton (T.I.) - all in the United Kingdom; Hôpital Européen Georges-Pompidou, Sorbonne Paris Cite/Paris Descartes University (J.T.), and Saint-Antoine Hospital and Sorbonne Universités, Pierre and Marie Curie University-Paris 6 (T.A.), Paris, and Methodology and Quality of Life Unit, INSERM Unité 1098, Besançon (D.V.) - all in France; the Department of Medical Oncology, University Hospital of Heraklion, Faculty of Medicine, University of Crete, Heraklion (J.S.), and Bioclinic Thessaloniki, Thessaloniki (I.B.) - both in Greece; Dana-Farber Cancer Institute, Boston (J.A.M.); and Duke Cancer Institute, Durham, NC (D.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1713709DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426127PMC
March 2018

BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer.

J Clin Oncol 2017 Aug 9;35(23):2624-2630. Epub 2017 May 9.

Jeremy C. Jones, Lindsay A. Renfro, Ben Y. Zhang, Pashtoon M. Kasi, Jesse S. Voss, Alexis D. Leal, Joleen M. Hubbard, Benjamin R. Kipp, Robert R. McWilliams, and Axel Grothey, Mayo Clinic, Rochester, MN; Humaid O. Al-Shamsi, Scott Kopetz, and Robert A. Wolff, The University of Texas MD Anderson Cancer Center, Houston, TX; and Alexa B. Schrock, Andrew Rankin, James Sun, Jeffrey Ross, and Siraj M. Ali, Foundation Medicine, Cambridge, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.4394
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.4394DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549454PMC
August 2017

Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database.

J Clin Oncol 2017 Jun 17;35(17):1929-1937. Epub 2017 Apr 17.

Lindsay A. Renfro, Axel Grothey, and Daniel J. Sargent, Mayo Clinic, Rochester, MN; Richard M. Goldberg, The Ohio State University, Columbus, OH; Alberto Sobrero, Ospedale San Martino, Genoa; Alfredo Falcone, University Hospital of Pisa, Pisa, Italy; Richard Adams, Cardiff University, Cardiff; Matthew T. Seymour, St James's Hospital and University of Leeds, Leeds, United Kingdom; Volker Heinemann, University of Munich, Munich; Hans-Joachim Schmoll, University Clinic Halle (Saale), Halle; Rainer Porschen, Klinikum Bremen-Ost Klinik für Innere Medizin, Bremen; Carsten Bokemeyer, University Hospital, Hamburg-Eppendorf, Germany; Jean-Yves Douillard, Centre René Gauducheau, Nantes; Christophe Tournigand, University of Paris Est Creteil; Christophe Tournigand, Assistance Hopitaux Publique de Paris Henri-Mondor Hospital, Créteil; Benoist Chibaudel and Aimery de Gramont, Franco-British Institute, Levallois-Perret, France; Herbert Hurwitz, Duke University Medical Center, Durham, NC; Charles S. Fuchs; Dana-Farber Cancer Institute, Boston, MA; Eduardo Diaz-Rubio, Hospital Clínico San Carlos, Universidad Complutense, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain; Paulo M. Hoff, Hospital Sírio-Libanês and University of São Paulo, São Paulo, Brazil; Fairooz F. Kabbinavar and J. Randolph Hecht, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA; Niall C. Tebbutt, Austin Health, Heidelberg, Victoria, Australia; Cornelis J.A. Punt, University of Amsterdam, Amsterdam, the Netherlands; John Souglakos, University of Crete, Heraklion, Greece; Eric Van Cutsem, University Hospital Leuven, Leuven, Belgium; and Leonard Saltz, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.5771DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466009PMC
June 2017

Anorectal Function and Quality of Life in Patients With Early Stage Rectal Cancer Treated With Chemoradiation and Local Excision.

Dis Colon Rectum 2017 May;60(5):459-468

1 Colorectal Service, Memorial Sloan Kettering Cancer Center, New York, New York 2 Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DCR.0000000000000758DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384260PMC
May 2017

Precision oncology: A new era of cancer clinical trials.

Cancer Lett 2017 02 14;387:121-126. Epub 2016 Mar 14.

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03043835163016
Publisher Site
http://dx.doi.org/10.1016/j.canlet.2016.03.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023449PMC
February 2017

Findings from the Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group: the power of pooled individual patient data from multiple clinical trials.

Chin Clin Oncol 2016 Dec;5(6):80

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2016.12.02DOI Listing
December 2016

Surrogate End Points in Soft Tissue Sarcoma: Methodologic Challenges.

J Clin Oncol 2016 11;34(32):3949-3950

Lindsay A. Renfro, Qian Shi, and Daniel J. Sargent, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.8730DOI Listing
November 2016

Impact of Copula Directional Specification on Multi-Trial Evaluation of Surrogate End Points.

J Biopharm Stat 2015 ;25(4):857-77

a Division of Biomedical Statistics and Informatics , Mayo Clinic , Rochester , Minnesota , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10543406.2014.920870DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270950PMC
April 2016

Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database.

J Clin Oncol 2016 Apr 8;34(11):1182-9. Epub 2016 Feb 8.

Winson Y. Cheung, British Columbia Cancer Agency, Vancouver, British Columbia; Chris O'Callaghan, Queen's University, Kingston, Ontario, Canada; Lindsay A. Renfro, Axel Grothey, Steven R. Alberts, and Daniel J. Sargent, Mayo Clinic, Rochester, MN; David Kerr, University of Oxford, Oxford; Chris Twelves, University of Leeds and St James Institute of Oncology, Leeds, United Kingdom; Aimery de Gramont, Franco-British Institute, Levallois-Perret; Thierry Andre, Hospital Saint-Antoine and Pierre and Marie Curie University, Paris; Jean-Francois Seitz, La Timone Hospital, Aix-Marseille University, Marseille, France; Leonard B. Saltz, Memorial Sloan Kettering Cancer Center, New York, NY; Katherine A. Guthrie, Fred Hutchinson Cancer Center, Seattle, WA; Roberto Labianca, Ospedale Giovanni XXIII, Bergamo; Guido Francini, University of Siena, Siena, Italy; Eric Van Cutsem, University Hospital Leuven, Leuven, Belgium; Daniel G. Haller, University of Pennsylvania, Philadelphia; and Greg Yothers, University of Pittsburgh, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.1158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933130PMC
April 2016

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Colon Cancer End Points (ACCENT) Database.

J Clin Oncol 2016 Mar 25;34(8):843-53. Epub 2016 Jan 25.

Manish A. Shah, Weill Cornell Medical College, New York/Presbyterian Hospital, New York, NY; Lindsay A. Renfro, Steven R. Alberts, and Daniel J. Sargent, Mayo Clinic, Rochester, MN; Carmen J. Allegra, University of Florida, Gainesville, FL; Thierry André, Hôpital Saint Antoine, Paris; Aimery de Gramont, Franco-British Institute, Levallois-Perret, France; Hans-Joachim Schmoll, University Clinic Halle (Saale), Halle, Germany; Daniel G. Haller, University of Pennsylvania, Philadelphia; and Greg Yothers, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/01/21/JCO.2015.63
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.63.0558
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.63.0558DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872008PMC
March 2016

Clinical trial designs incorporating predictive biomarkers.

Cancer Treat Rev 2016 Feb 5;43:74-82. Epub 2016 Jan 5.

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2015.12.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737867PMC
February 2016

Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database.

J Clin Oncol 2016 Jan 26;34(2):144-50. Epub 2015 Oct 26.

Lindsay A. Renfro and Daniel J. Sargent, Mayo Clinic, Rochester, MN; Fotios Loupakis and Alfredo Falcone, Azienda Ospedaliero-Universitaria Pisana and Università di Pisa, Pisa, Italy; Richard Adams, Cardiff University, Cardiff; Matthew T. Seymour, St James's Hospital and University of Leeds, Leeds, United Kingdom; Volker Heinemann, University of Munich, Munich; Hans-Joachim Schmoll, University Clinic Halle (Saale), Halle; Rainer Porschen, Klinikum Bremen-Ost Klinik für Innere Medizin, Bremen; Carsten Bokemeyer, University Hospital Cancer Center, University Hospital, Hamburg-Eppendorf, Germany; Jean-Yves Douillard, Institut de Cancerologie, Centre René Gauducheau, Nantes; Christophe Tournigand, University of Paris Est Creteil, Henri-Mondor Hospital, Créteil; Benoist Chibaudel and Aimery de Gramont, Franco-British Institute, Levallois-Perret, France; Herbert Hurwitz, Duke University Medical Center, Durham, NC; Charles S. Fuchs, Dana-Farber Cancer Institute Boston, MA; Eduardo Diaz-Rubio, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain; Niall C. Tebbutt, Austin Health, Heidelberg, Victoria, Australia; Cornelis J.A. Punt, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; J. Randolph Hecht, David Geffen School of Medicine at the University of California at Los Angeles; Heinz-Josef Lenz, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA; Eric Van Cutsem, University Hospital Leuven, Leuven, Belgium; Richard M. Goldberg, Ohio State University, Columbus, OH; and Leonard B. Saltz, Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.6441DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070548PMC
January 2016

Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer.

J Thorac Oncol 2015 Jul;10(7):1099-106

*Division of Biomedical Statistics and Informatics, Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota; †Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona; ‡Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; §Department of Biostatistics and Bioinformatics, Alliance Statistics and Data Center, Duke University, Durham, North Carolina; ‖Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; ¶Department of Oncology, NCIC Clinical Trials Group, Queen' University, Kingston, ON, Canada; #Department of Hematology & Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia; **Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, California; ††Department of Statistics for the Data Center/Operations Office, Japan Clinical Oncology Group Data Center, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan; ‡‡Department of Medical Oncology, Japanese Society of Medical Oncology, Tokyo, Japan; §§Department of Medicine, The University of Chicago Medicine and Biologic Sciences Center, Chicago, Illinois; and ‖‖Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153349
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000548DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493926PMC
July 2015

Germline variation in colorectal risk Loci does not influence treatment effect or survival in metastatic colorectal cancer.

PLoS One 2014 11;9(4):e94727. Epub 2014 Apr 11.

DeBartolo Family Personalized Medicine Institute, Division of Population Sciences, Moffitt Cancer Center, Tampa, Florida, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0094727PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984266PMC
May 2015

ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer.

J Natl Cancer Inst 2014 Dec 29;106(12). Epub 2014 Oct 29.

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN (LAR, DJS); Department of Oncology, Mayo Clinic, Rochester, MN (AMG, SRA, CLL); Department of Statistics, University of Virginia, Charlottesville, VA (YX); Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY (LBS); Hôpital Saint Antoine, Paris, France; Pierre and Marie Curie University, Paris, France (TA); Leeds Institute of Cancer and Pathology, University of Leeds and St. James's University Hospital, Leeds Cancer Research UK Centre, UK (CT); Oncology Unit, Ospedale Giovanni XXIII, Bergamo, Italy (RL); Division of Hematology and Oncology, University of Florida, Gainesville, FL (CJA); National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Pittsburgh, PA (GY).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/106/12/dju333.full.pd
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/dju333
Publisher Site
http://dx.doi.org/10.1093/jnci/dju333DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334801PMC
December 2014

Center-Within-Trial Versus Trial-Level Evaluation of Surrogate Endpoints.

Comput Stat Data Anal 2014 Oct;78:1-20

Division of Biomedical Statistics and Informatics, Mayo Clinic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.csda.2014.03.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104720PMC
October 2014

Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients.

Oncologist 2014 May 7;19(5):492-7. Epub 2014 Apr 7.

Mayo Clinic, Rochester, Minnesota, USA, Medical Oncology and Hematology Associates, Des Moines, Iowa, USA; Genomic Health, Inc., Redwood City, California, USA; Alegent Bergan Mercy Cancer Center, Omaha, Nebraska, USA; Cancer Center of Kansas, Wichita, Kansas, USA; Toledo Clinic, Toledo, Ohio, USA; Columbus Oncology Associates, Columbus, Ohio, USA; Mayo Clinic, Jacksonville, Florida, USA; Sanford Hospital, Sioux Falls, South Dakota, USA.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2013-0401DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012966PMC
May 2014

Adaptive randomized phase II design for biomarker threshold selection and independent evaluation.

Chin Clin Oncol 2014 Mar;3(1)

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://www.thecco.net/article/view/3489/4336
Publisher Site
http://dx.doi.org/10.3978/j.issn.2304-3865.2013.12.04DOI Listing
March 2014

Mining the ACCENT database: a review and update.

Chin Clin Oncol 2013 Jun;2(2):18

Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2013.03.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407359PMC
June 2013

Chronic consequences of acute injuries: worse survival after discharge.

J Trauma Acute Care Surg 2012 Sep;73(3):699-703

Institute for Health Care Research and Improvement, Baylor Health Care System, Dallas, Texas 76051, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TA.0b013e318253b5dbDOI Listing
September 2012

Bayesian adjusted R2 for the meta-analytic evaluation of surrogate time-to-event endpoints in clinical trials.

Stat Med 2012 Apr 9;31(8):743-61. Epub 2011 Dec 9.

Cancer Center Statistics, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/sim.4416
Publisher Site
http://dx.doi.org/10.1002/sim.4416DOI Listing
April 2012

Bayesian adaptive trial design for a newly validated surrogate endpoint.

Biometrics 2012 Mar 12;68(1):258-67. Epub 2011 Aug 12.

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1541-0420.2011.01647.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218207PMC
March 2012